Amgen Inc. on Thursday said it would lay off about 450 employees, or less than 2% of its workforce, as it faces increasing pressure from drug prices and high inflation. “We made these changes to ...
Amgen's new research and development facility in San Francisco. (courtesy photo) For the second time this year, Amgen is ...
The outlet also reported that another 100 workers could lose jobs at the firm’s Scarborough, ME plant. The company said the laid-off employees would be offered severance packages and would be ...
Lowenstein lays off 16 business professionals across three offices. The layoffs come even after the firm had a strong financial showing in 2022. Lowenstein Sandler, fresh off a year in which ...
Twilio is laying off nearly 1,000 employees, as the cloud communications specialist says it simply grew too fast and needs to focus on profitability and core priorities. However, some of the sta ...
Microsoft laid off its entire ethics and society team within the artificial intelligence organization as part of recent layoffs that affected 10,000 employees across the company, Platformer has ...
Leafly is laying off 40 employees, about 21% of its workforce, as it looks to conserve cash and reach profitability amid various headwinds affecting the cannabis company’s business. The company ...
Two days before that announcement, nearly all the studio’s 16 employees were laid off by Hudson Pacific Properties, the real estate investment company that purchased the building in 2013.
Note: Vacasa initially said that it laid off 240 in the Portland area. The company subsequently reported it had dramatically overstated that total, and that it actually had 240 Portland employees ...
Twitter has laid off at least 200 staff in another round of cuts, according to reports in the New York Times. It said the tech giant had cut 10% of its current workforce, which it estimated at ...
(Reuters) -Amgen Inc said on Thursday it would cut 450 jobs, or less than 2% of its workforce, making it the company's second round of layoffs this year amid intensifying pressure on drug prices ...
